Skip to main content
. Author manuscript; available in PMC: 2020 Sep 12.
Published before final editing as: Cancer. 2019 Mar 12:10.1002/cncr.32056. doi: 10.1002/cncr.32056

Figure 2. Survival curves by CHIP-associated mutations.

Figure 2

Figure 2

A: Patients harboring CHIP-associated mutations had slightly lower overall survival compared to those without the mutations. B: When TP53 mutations were removed from the overall survival calculations, the effect of CHIP-associated mutations on survival was non-significant.